Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Feist

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Plos One|August 23, 2011
Landscape ecotoxicology of coho salmon spawner mortality in urban streamsBlake E Feist, Eric R Buhle, Paul Arnold, et al.
Calcified Tissue International|November 1, 1979
Bone mineralization and metabolism of 3H-25-hydroxyvitamin D3 in thyroparathyroidectomized rats treated with parathyroid extractJ I Rader, G A Howard, E Feist, et al.
Annals of the Rheumatic Diseases|January 18, 2006
Immunoproteasome subunit LMP2 expression is deregulated in Sjogren's syndrome but not in other autoimmune disordersS Krause, U Kuckelkorn, T Dörner, et al.
Annals of the Rheumatic Diseases|March 14, 2003
A unique autoantibody pattern of positive anti-Jo-1, anti-U1RNP, and antiproteasome antibodies in autoimmune myositis as a diagnostic challengeE Feist, M-L Schneider, M Brychcy, et al.
Arthritis Care & Research|August 9, 2013
Usefulness of power Doppler ultrasound for prediction of re-therapy with rituximab in rheumatoid arthritis: a prospective study of longstanding rheumatoid arthritis patientsB E Reiche, S Ohrndorf, E Feist, et al.
Annals of the Rheumatic Diseases|June 15, 2004
Benefit of immunosuppression for severe Takayasu's arteritis and coincident primary biliary cirrhosisE Feist, K G A Hermann, S Filimonow, et al.
Annals of the Rheumatic Diseases|January 29, 2010
IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's diseaseL Naumann, E Feist, A Natusch, et al.
Journal of Vitreoretinal Diseases|June 16, 2025
Long-Term Cost Analysis of Initial Panretinal Photocoagulation for Proliferative Diabetic Retinopathy Performed in the Operating Room vs the ClinicSean C Drummond, Brenton T Bicknell, Jack E Feist, et al.
Journal of Vitreoretinal Diseases|August 16, 2024
Peripheral PRP in the Operating Room vs Standard Clinic PRP for the Initial Treatment of PDRJack E Feist, Sean C Drummond, Jonathan S Fuerst, et al.
Annals of the Rheumatic Diseases|December 29, 2010
Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)Gerd R Burmester, E Feist, H Kellner, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Plos One|August 23, 2011
Landscape ecotoxicology of coho salmon spawner mortality in urban streamsBlake E Feist, Eric R Buhle, Paul Arnold, et al.
Calcified Tissue International|November 1, 1979
Bone mineralization and metabolism of 3H-25-hydroxyvitamin D3 in thyroparathyroidectomized rats treated with parathyroid extractJ I Rader, G A Howard, E Feist, et al.
Annals of the Rheumatic Diseases|January 18, 2006
Immunoproteasome subunit LMP2 expression is deregulated in Sjogren's syndrome but not in other autoimmune disordersS Krause, U Kuckelkorn, T Dörner, et al.
Annals of the Rheumatic Diseases|March 14, 2003
A unique autoantibody pattern of positive anti-Jo-1, anti-U1RNP, and antiproteasome antibodies in autoimmune myositis as a diagnostic challengeE Feist, M-L Schneider, M Brychcy, et al.
Arthritis Care & Research|August 9, 2013
Usefulness of power Doppler ultrasound for prediction of re-therapy with rituximab in rheumatoid arthritis: a prospective study of longstanding rheumatoid arthritis patientsB E Reiche, S Ohrndorf, E Feist, et al.
Annals of the Rheumatic Diseases|June 15, 2004
Benefit of immunosuppression for severe Takayasu's arteritis and coincident primary biliary cirrhosisE Feist, K G A Hermann, S Filimonow, et al.
Annals of the Rheumatic Diseases|January 29, 2010
IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's diseaseL Naumann, E Feist, A Natusch, et al.
Journal of Vitreoretinal Diseases|June 16, 2025
Long-Term Cost Analysis of Initial Panretinal Photocoagulation for Proliferative Diabetic Retinopathy Performed in the Operating Room vs the ClinicSean C Drummond, Brenton T Bicknell, Jack E Feist, et al.
Journal of Vitreoretinal Diseases|August 16, 2024
Peripheral PRP in the Operating Room vs Standard Clinic PRP for the Initial Treatment of PDRJack E Feist, Sean C Drummond, Jonathan S Fuerst, et al.
Annals of the Rheumatic Diseases|December 29, 2010
Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)Gerd R Burmester, E Feist, H Kellner, et al.
Pageof 9